News | Coronavirus (COVID-19) | May 19, 2021

Recognition of abnormal axillary lymph node or deltoid uptake on PET examinations performed after COVID-19 vaccination aid interpreting physicians and reduce unnecessary biopsies

According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), increased axillary lymph node or ipsilateral deltoid uptake is occasionally observed on FDG or 11C-choline PET performed after Pfizer-BioNTech or Moderna COVID-19 vaccination

(A) 57-year-old woman with right upper arm melanoma who received the first dose of the COVID-19 vaccine (Pfizer-BioNTech) in the left deltoid 15 days prior to FDG PET/CT. FDG uptake is observed within left axillary lymph nodes (arrow, SUVmax = 9.3).

(B) 62-year-old man with metastatic prostate carcinoma who received the second dose of COVID-19 vaccine (Pfizer-BioNTech) in the right deltoid 7 days prior to 11C-choline PET/CT. 11C-choline uptake is observed within right axillary lymph nodes (arrows, SUVmax = 3.1) as well as the right deltoid muscle (circle, SUVmax = 1.7).


May 19, 2021 — According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), increased axillary lymph node or ipsilateral deltoid uptake is occasionally observed on FDG or 11C-choline PET performed after Pfizer-BioNTech or Moderna COVID-19 vaccination.

“Recognition of occasional abnormal axillary lymph node or deltoid uptake on PET examinations performed after COVID-19 vaccination will aid interpreting physicians and reduce unnecessary biopsies,” wrote corresponding author Jason R. Young from the department of radiology at Mayo Clinic in Rochester, Minn.

Young and colleagues’ retrospective study included 67 patients (43 men, 24 women; mean age, 75.6 years) who underwent PET examination (PET/CT in 66, PET/MRI in 1; FDG in 54, 11C-choline in 13) between December 14, 2020 and March 10, 2021 following COVID-19 vaccination (Pfizer-BioNTech vaccine in 52, Moderna vaccine in 15) and who had undergone pre-vaccination PET without visible axillary node uptake. PET was performed a median of 13 and 10 days after vaccination in patients who had received one (n = 44) and two (n = 23) doses, respectively.

“We observed positive axillary lymph nodes in 7.4% of FDG and 23.1% of 11C-choline PET examinations performed after COVID-19 vaccination (10.4% of PET examinations) in patients without visible axillary nodal uptake on PET performed before vaccination,” Young et al. concluded. Ipsilateral deltoid uptake with a characteristic appearance was observed in 14.5% of examinations, and one patient exhibited extraaxillary lymph node uptake (ipsilateral supraclavicular uptake on FDG PET).

“All examinations showing positive axillary lymph nodes were performed within 24 days of vaccination,” the authors of this AJR article added.

For more information: www.arrs.org

 

Related COVID Vaccine Axillary Adenapathy Content:

COVID-19 Vaccine Can Cause False Positive Cancer Diagnosis

Help Spread Awareness of Potential COVID-19 Vaccine Imaging Side-effects

VIDEO: COVID Vaccine May Cause Enlarged Lymph Nodes on Mammograms — Interview with Constance "Connie" Lehman, M.D.

COVID-19 Vaccination Axillary Adenopathy Detected During Breast Imaging

CMS Now Requires COVID-19 Vaccinations for Healthcare Workers by January 4

PHOTO GALLERY: How COVID-19 Appears on Medical Imaging

Find more radiology related COVID content 


Related Content

News | Computed Tomography (CT)

Sept. 17, 2026 — Royal Philips and Southwest Mississippi Regional Medical Center (SMRMC), which serves as the hub of ...

Time September 24, 2026
arrow
News | Radiology Education

Sept. 16, 2026 — As urgent care centers and outpatient healthcare facilities expand their use of diagnostic imaging, the ...

Time September 17, 2026
arrow
News | PET Imaging

Sept. 10, 2026 — Siemens Healthineers Molecular Imaging has completed a $43.6 million construction and renovation ...

Time September 14, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

A radiologist pulls up a chest CT scan flagged for a pulmonary nodule. One artificial intelligence (AI) tool writes its ...

Time September 09, 2026
arrow
News | Radiopharmaceuticals and Tracers

Aug. 30, 2026 — Bayer has announced the presentation of first detailed results from the Phase III REVEAL study, an ...

Time September 02, 2026
arrow
News | Radiology Business

August 18, 2026 – NewVue, a provider of cloud-native software that unifies how radiologists work while improving ...

Time August 25, 2026
arrow
Feature | Artificial Intelligence | Madhu Jahagirdar

Radiologists spend much of their day moving between different systems: One application to review images. Another to ...

Time August 17, 2026
arrow
News | X-Ray

Aug. 10, 2026 — Teledyne Technologies Inc. and Varex Imaging Corp. have jointly announced that they have entered into a ...

Time August 14, 2026
arrow
News | FDA

Aug. 1, 2026 — Candelis recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

Time August 13, 2026
arrow
News | Artificial Intelligence

Aug. 10, 2026 — OSF HealthCare, a not-for-profit health system serving communities across Illinois and Michigan, and ...

Time August 12, 2026
arrow
Subscribe Now